Synergistic DNA–MVA prime-boost vaccination regimes for malaria and tuberculosis

This publication has 39 references indexed in Scilit:

• Boosting with Poxviruses Enhances Mycobacterium bovis BCG Efficacy against Tuberculosis in Guinea Pigs
  Infection and Immunity, 2005
• A Heterologous DNA Priming- Mycobacterium bovis BCG Boosting Immunization Strategy Using Mycobacterial Hsp70, Hsp65, and Apa Antigens Improves Protection against Tuberculosis in Mice
  Infection and Immunity, 2004
• A Randomised, Double-Blind, Controlled Vaccine Efficacy Trial of DNA/MVA ME-TRAP Against Malaria Infection in Gambian Adults
  PLoS Medicine, 2004
• Phase 1 Evaluation of 3 Highly Immunogenic Prime‐Boost Regimens, Including a 12‐Month Reboosting Vaccination, for Malaria Vaccination in Gambian Men
  The Journal of Infectious Diseases, 2004
• Comparison of the genome sequence of FP9, an attenuated, tissue culture-adapted European strain of Fowlpox virus, with those of virulent American and European viruses
  Journal of General Virology, 2004
• Safety and Immunogenicity of DNA/Modified Vaccinia Virus Ankara Malaria Vaccination in African Adults
  The Journal of Infectious Diseases, 2003
• A DNA Prime- Mycobacterium bovis BCG Boost Vaccination Strategy for Cattle Induces Protection against Bovine Tuberculosis
  Infection and Immunity, 2003
• Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine
  Science, 2001
• Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV‐1_Mngp120, HIV‐1_SF2Recombinant gp120, or Both Vaccines in Seronegative Adults
  The Journal of Infectious Diseases, 1998
• Polymorphism of the TRAP gene ofPlasmodium falciparum
  Proceedings Of The Royal Society B-Biological Sciences, 1990